GC
Geoff Cuvelier
CancerCare Manitoba
Research areas: Medicine · Hematology · Hematopoietic Stem Cell Transplantation · Immunodeficiency and Autoimmune Disorders · Transplantation: Methods and Outcomes
0000-0003-4493-8757
Employment
-
CancerCare Manitoba Physician2008 - Present
Education
Projects & Funding
-
Metabolomics for the prediction of cisplatin induced acute kidney injury: a Canadian multicentre adult and pediatric study Canadian Institutes of Health Research2019 - 2025
-
Precision Oncology for Young People (PROFYLE)” CancerCare Manitoba Foundation2017 - 2022
-
Immune Response to Polysaccharides in Transplantation Canadian Glycomics Network2017 - 2019
-
Preparing for Combined Stem Cell and Solid Organ Transplants: Learning from Hematopoietic Mixed Chimeras Canadian Donation and Transplantation Research Program Team Grant2016 - 2019
-
Heterozygous IKBKB mutations in Manitoba’s Northern First Nation Children Manitoba Institute of Child Health2013 - 2014
-
Lipid Mediators in the Inflammatory Complications of Blood and Marrow Transplantation CancerCare Manitoba Foundation2012 - 2014
-
Applying Biomarkers to Long-Term Effects in Children and Adolescent Cancer Treatment (ABLE Team) Canadian Institutes of Health Research2012 - 2017
Publications (66)
- The diagnosis of severe combined immunodeficiency (SCID): The Primary Immune Deficiency Treatment Consortium (PIDTC) 2022 Definitions. Save
- The diagnosis of severe combined immunodeficiency: Implementation of the PIDTC 2022 Definitions. Save
- Acute kidney injury during cisplatin therapy and associations with kidney outcomes 2 to 6 months post-cisplatin in children: a multi-centre, prospective observational study. Save
- A diagnostic classifier for pediatric chronic graft-versus-host disease: results of the ABLE / PBMTC 1202 study. Save
- CD56brightCD16- natural killer cells as an important regulatory mechanism in chronic graftversus-host disease. Save
- Aberrant T-cell exhaustion in severe combined immunodeficiency survivors with poor T-cell reconstitution after transplantation. Save
- Outcomes following treatment for ADA-deficient severe combined immunodeficiency: a report from the PIDTC. Save
- Toward a Better Understanding of the Atypical Features of Chronic Graft-Versus-Host Disease: A Report from the 2020 National Institutes of Health Consensus Project Task Force. Save
- Is It Possible to Separate the Graft-Versus-Leukemia (GVL) Effect Against B Cell Acute Lymphoblastic Leukemia From Graft-Versus-Host Disease (GVHD) After Hematopoietic Cell Transplant? Save
- Association Between the Magnitude of Intravenous Busulfan Exposure and Development of Hepatic Veno-Occlusive Disease in Children and Young Adults Undergoing Myeloablative Allogeneic Hematopoietic Cell Transplantation. Save
- Poor outcome after hematopoietic stem cell transplantation of patients with unclassified inherited bone marrow failure syndromes. Save
- Metabolomic identification of α-ketoglutaric acid elevation in pediatric chronic graft-versus-host disease. Save
- Granulocyte Colony-Stimulating Factor Is Safe and Well Tolerated following Allogeneic Transplantation in Patients with Sickle Cell Disease. Save
- A Canadian Study of Cisplatin Metabolomics and Nephrotoxicity (ACCENT): A Clinical Research Protocol. Save
- Urine Neutrophil Gelatinase-Associated Lipocalin and Kidney Injury Molecule-1 to Detect Pediatric Cisplatin-Associated Acute Kidney Injury. Save
- Diagnostic and treatment intervals are not associated with survival in rhabdomyosarcoma: A Cancer in Young People in Canada study. Save
- National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. The 2020 Highly morbid forms report. Save
- Association between Antiviral Prophylaxis and Cytomegalovirus and Epstein-Barr Virus DNAemia in Pediatric Recipients of Allogeneic Hematopoietic Stem Cell Transplant. Save
- Risk factors for post-transplant Epstein-Barr virus events in pediatric recipients of hematopoietic stem cell transplants. Save
- National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IIa. The 2020 Clinical Implementation and Early Diagnosis Working Group Report. Save